Khaled Asi, MD
Neurology · Cleveland, OHNPI 1710150438
Payments from drug & device makers
Across 144 payments — averaging $197.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$12K
- Depuy Synthes Products, Inc.$5K
- Scientia Vascular$4K
- Penumbra, Inc.$2K
- Stryker$2K
- Johnson & Johnson$1K
- plus $3K from 10 others
What the payments were for
- Consulting fees$12,74045%
- Travel & lodging$10,72838%
- Food & beverage$4,92217%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 36 | $12,132 |
| Depuy Synthes Products, Inc. | 1 | $5,175 |
| Scientia Vascular | 5 | $3,580 |
| Penumbra, Inc. | 12 | $2,187 |
| Stryker | 9 | $1,514 |
| Johnson & Johnson | 41 | $1,096 |
| Microvention, Inc. | 9 | $1,023 |
| Medtronic | 14 | $854 |
| Balt USA, LLC | 5 | $320 |
| Imperative Care, Inc | 2 | $197 |
| Route 92 Medical, Inc. | 1 | $108 |
| AstraZeneca(2 entities) | 5 | $104 |
| Cardiva Medical, Inc. | 1 | $31 |
| Cordis US CORP. | 1 | $29 |
| CSL Behring | 1 | $26 |
| KCI USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBOGUARD$9,602
- SPOTLIGHT$5,175
- Aristotle Guidewire$2,504
- PULSERIDER$1,302
- TRUFILL$1,302
- TREVO$1,174
- Benchmark$933
- Smart Coil$815
- WEB$728
- LVIS$600
- HydroSoft 3D Coil$600
- Traxcess Guidewire and Docking Wire$600
- Sofia$600
- Pipeline$440
- Optima Coil System$180
- Socrates 38$159
- Colossus$159
- Plato 17$159
- RED 72$142
- ZOOM 88-T LARGE DISTAL PLATFORM$135
How this compares
$28,390 in reported general payments places this provider in the 70th percentile of 702 neurology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 14 | $127 |
Paid to pharmacies, not to this prescriber.
Other neurology in Cleveland
- Robert BermelCleveland$6.4M
- Jeffrey CohenCleveland$3.1M
- Yuebing LiCleveland$1.4M
- Devon ConwayCleveland$1.3M
- Robert FoxCleveland$1.3M
- Glen StevensCleveland$1.1M
- Hubert FernandezCleveland$1.1M
- Hesham AbboudCleveland$1.1M
- Michal GostkowskiCleveland$850K
- Daniel OntanedaCleveland$838K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.